The Private Insurance Activation in the Global Medical Competitional Age and the Counterplot of the Medical Profession

The year 2007 US-Korea FTA contracting may have removed a international border hurdle in terms of custom tax problem that may have been protected by each country. After that, there remains an infinite competition between the two countries for international trades especially for medical service. Private medical insurance can play an important role in suppressing oversea hospital use in top-level medical consumers and in introducing the high-level of domestic medical technology to low-income medical consumers. And thus, the private insurance system is expected to lead the patients of both extremes in terms of their salary income to domestic medical consumption. Private medical insurance system is also expected to help lessen medical expenses and lower the price of pre-existing medical technology. For activating normally the private medical insurance, one of practical methods is to ensure the neutralized and efficient network by the central role play of medical profession groups. Now is the high change that we can make a better medical welfare environment, if the advantage and the meaning of each insurance (including private insurance system) institution can be substantiated.

Bioabsorbable Skeletal Fixation System Devices in Reduction for Facial Bone Fracture

The rigid metal fixation devices are currently the most widely used in maxillofacial surgery. The use of metal plate and screw fixation, however, is not free of some postoperative complication. Once the fractures have healed, metal devices no longer serve any tissue purpose other than the potential for adverse reaction, including loosening, palpability, corrosion, and artifacts in CT and MRI, and they restrict growth of the neurocranium. To overcome these drawbacks, there had been a continuous research on the development of a bioabsorbable skeletal fixation system using polymers of polylactic and polyglycolic acid. There is an increasing acceptance of there use as an alternative fixation device in craniomaxillofacial surgery. We have used the BiosorbFX(R) system(Bionix Implants Ltd) in 48 patients of facial bone fractures. Age varied from 3 to 70(mean 34) and follow up period varied form 1 months to 10 months(mean 5 months). A total of 860 bioabsorbable devices(151 plates and 709 screws) was used. We encountered no significant intraoperative difficulties in obtaining placement of the devices. No patients has experienced any implant-related complications including infection, fracture instability or relapse, or radiographic evidence of osteolysis. The use of nonmetallic materials as a fixation devices that will be resorbed after facial bone fracture healing, therefore, would have advantages. The good results indicate that the use of bioabsorbable implants can be considered for the fixation of facial bone fractures.